Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P120020/S035

Supera Peripheral Stent System

Abbott Vascular (Idef Technologies Inc) · Decision date Feb 5, 2026

FDA DECISIONP120020/S035

What did the FDA decide?

FDA records P120020/S035 as a supplement to PMA P120020, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 5, 2026.

FDA approval order statement

approval for a change to the outer sheath coating solution process
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Feb 5, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P120020/S035
Regulatory pathway
PMA supplement
Product code
NIP
Decision code
OK30
Decision date
Feb 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.

Product code
NIP
FDA device class
3

For the original device and its historical approval scope, see PMA P120020. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P120020 · Original PMA

    SUPERA PERIPHERAL STENT SYSTEM

  2. P120020/S034 · Related supplement

    Supera Peripheral Stent System

  3. P120020/S035 received

    Application receipt date recorded by FDA.

  4. P120020/S035 · FDA decision

    30-Day Notice

  5. P120020/S036 · Related supplement

    Supera Peripheral Stent System

  6. P120020/S037 · Related supplement

    Supera Peripheral Stent System

Timeline entries are records held by MedtechLedger for P120020. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P120020

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Vascular (Idef Technologies Inc)PMA approvalMar 28, 2014FDA
Abbott Vascular (Idef Technologies Inc)PMA supplementDec 9, 2025FDA
Abbott Vascular (Idef Technologies Inc)PMA supplementMar 20, 2026FDA
Abbott Vascular (Idef Technologies Inc)PMA supplementNov 6, 2026FDA

Explore the linked device profile

Other records with product code NIP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Vascular (Idef Technologies Inc)

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3200 Lakeside Dr., Santa Clara, CA, 95054

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records